| 词条 | IL Therapeutics |
| 释义 |
|name = IL Therapeutics Inc. |type = |foundation = |location =105E ñ 111 Research Drive, Saskatoon, SK, Canada |key_people = | industry = Biotechnology | num_employees = | products = | homepage = }} IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP ("Western Life Sciences") and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation ("Pacgen").[1][2] HistorySaskatchewan Research Council operates a bioprocessing laboratory which facilitated biomedical research. IL Therapeutics was developed from research first begun at the Western College of Veterinary Medicine. PharmaceuticalsCurrently IL Therapeutics is working on a drug candidate, IL-8(3-73)K11R/G31P ("PAC-G31P") for relief of Acute Respiratory Distress Syndrome (ARDS).[1] The Saskatchewan Research council, SRC also assisted with the funding of this project through the Agriculture Development Fund - SRC Industry Venture Fund.[3] With the successful progression of G31P, the University of Saskatchewan Industry Liaison Office (ILO) decided to commercialize a commercialize this new drug treatment.[4] This research has been sponsored by a $3 million boost from the Western Life Sciences Venture Fund (WLS)[5] See also
References1. ^1 {{cite press release |title=Pacgen Biopharmaceuticals Acquires IL Therapeutics Inc. |date=April 12, 2006 |url=http://www.pacgenbiopharm.com/investor/pdfs/news_release20060412.pdf |archiveurl=https://web.archive.org/web/20110715032138/http://www.pacgenbiopharm.com/investor/pdfs/news_release20060412.pdf |archivedate=July 15, 2011 |publisher=Pacgen Biopharmaceuticals |accessdate=August 11, 2018}} 2. ^{{cite web |url=http://pacgenlife.com/node/137 |title=Pacgen Biopharmaceuticals Acquires IL Therapeutics Inc. |date=April 12, 2006 |publisher=Pacgen Biopharmaceuticals |accessdate=August 11, 2018}} 3. ^{{cite book | last =Saskatchewan Research Council 2005-2006 Annual Report | title =Sustainable Science Solutions |url =http://www.src.sk.ca/store/account/download_file.cfm?productID=3483&freeDownloadID=538 |pages=7–8 |archiveurl=https://web.archive.org/web/20110706203650/http://www.src.sk.ca/store/account/download_file.cfm?productID=3483&freeDownloadID=538 |archivedate=July 6, 2011 |accessdate=August 11, 2018}} 4. ^{{Citation| last =U of S News Releases: University Communication| first =| author-link =| last2 =| first2 =| author2-link =| title =U of S News Releases: U of S Signs Letter of Intent to Commercialize Treatment for Lung Injury Complications| date =| year =| url =http://announcements.usask.ca/news/archive/2004/05/u_of_s_signs_le.html| dead-url =yes| accessdate =Sep 9, 2007| archive-url =https://web.archive.org/web/20110706211730/http://announcements.usask.ca/news/archive/2004/05/u_of_s_signs_le.html| archive-date =2011-07-06| df =}} 5. ^{{cite journal |publisher=Saskatoon and District Chamber of Commerce |title=U of S News Releases: U of S Spin-off gets $3 Million Boost to Develop Anti-inflammatory Drug |date=December 2004 |journal=Business View |page=3 |url=https://www.saskatoonchamber.com/ckfinder/userfiles/files/Business%20View/BV_04_12.pdf |accessdate=August 11, 2018}} External links
{{med-company-stub}}{{Saskatchewan-stub}} 8 : Biotechnology companies established in 2005|Research institutes in Canada|University of Saskatchewan|Companies based in Saskatoon|Pharmaceutical companies of Canada|Biotechnology companies of Canada|Biotechnology companies disestablished in 2006|2006 mergers and acquisitions |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。